Silverback Therapeutics Inc logo

Silverback Therapeutics Inc

$ 5.87 0 (0%) 09:42 AM EST
P/E:
At Loss
P/B:
0.79
Market Cap:
$ 211.66M
Enterprise V:
$ -54.75M
Volume:
-
Avg Vol (2M):
-
Volume:
-
Market Cap $:
211.66M
PE Ratio:
At Loss
Avg Vol (2-Month):
-
Enterprise Value $:
-54.75M
PB Ratio:
0.79

Business Description

Description
Silverback Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on leveraging its ImmunoTAC technology platform to develop tissue targeted therapeutics for the treatment of cancer, chronic viral infections, and other serious diseases.
Name Current Vs Industry Vs History
Cash-To-Debt 1240.11
Equity-to-Asset 0.99
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year EBITDA Growth Rate 11.3
3-Year EPS without NRI Growth Rate 10.7
3-Year FCF Growth Rate 18

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 44
9-Day RSI 51.68
14-Day RSI 54.22
6-1 Month Momentum % 73.84
12-1 Month Momentum % -40.34

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 67.87
Quick Ratio 67.87
Cash Ratio 66.82

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -92.9
Name Current Vs Industry Vs History
ROE % -28.75
ROA % -27.3
ROIC % -196.73
ROC (Joel Greenblatt) % -1569.58
ROCE % -28.81